Jubilant Ingrevia Limited reports earnings for Q4FY21
Pharma

Jubilant Ingrevia Limited reports earnings for Q4FY21

Company has established strong levers of growth to deliver superior performance over the medium term.

  • By ICN Group | June 09, 2021

Jubilant Ingrevia Limited has posted a total revenue of Rs. 686.73 crore for the quarter ended on March 31, 2021. The company registered a net profit of Rs. 54.36 crore for the quarter.

Commenting on the company's performance, Shyam S Bhartia, Chairman and Hari S Bhartia, CoChairman, Jubilant Ingrevia Limited said: "We are glad to announce that we performed well during FY21. Despite the COVID-19 related challenges, we reported significant growth in our Revenue, EBITDA and PAT in FY21. All our sites remained operational throughout the pandemic and initiatives were taken to mitigate COVID-19 impacts. Supplies of raw material, availability of logistics were ensured for uninterrupted servicing of our customers and strict Covid protocols were followed at all our sites and offices for safety of our employees.

We also take this opportunity to thank all our employees who have worked tirelessly across all our plants and offices to ensure continuity in company's operations, while continuing to serve our global customers.

Demand scenario in all our business segments continue to be strong. Company has established strong levers of growth to deliver superior performance over the medium term.

As communicated to you earlier during our last communication, all growth plans are going on track and our FY'22 capex investment is estimated to be in range of Rs 300-350 Crore. The team is continuing to work towards meeting the plans.

The company reduced its net debt by Rs 594 Crore during FY21 and expects to reduce it further over the coming year."

Other Related stories

Startup

Chemical

Petrochemical

Digitization

Gas